*PROFARMY =?UTF-8?B?0JrRg9C/0LjRgtGMIC0g0KTQvtGA0LzQsCDQvtC00LXQttC00Ys=?=*

Компания PROFARMY является динамично развивающейся организацией в сфере военного обмундирования и снаряжения вот уже более 9 лет.via forma full 5 https://ift.tt/VWphYAB Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3579505.html)

PROFARMY =?UTF-8?B?0JrRg9C/0LjRgtGMIC0g0KTQvtGA0LzQsCDQvtC00LXQttC00Ys=?=

Компания PROFARMY является динамично развивающейся организацией в сфере военного обмундирования и снаряжения вот уже более 9 лет.via forma full 5 https://ift.tt/VWphYAB Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Национальная*

Федеральная служба войск национальной гвардии Российской Федерации (Росгвардия) — федеральный орган исполнительной власти Российской Федерации, спецслужба...via forma full 5 https://ift.tt/MYxFaSg Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3581058.html)

Национальная

Федеральная служба войск национальной гвардии Российской Федерации (Росгвардия) — федеральный орган исполнительной власти Российской Федерации, спецслужба...via forma full 5 https://ift.tt/MYxFaSg Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*«Google Диск» на Android адаптировали для планшетов и складных смартфонов*

Теперь приложение больше напоминает веб-версию.
[Read more...](https://lifehacker.ru/google-disk-adaptirovali-pod-planshety/)

*meirl*

submitted by /u/disfia to r/meirl [link] [comments]
[Read more...](https://www.reddit.com/r/meirl/comments/17zjb4h/meirl/)

meirl

submitted by /u/disfia to r/meirl link comments
Read more...

*Военизированная*

Военизированная охрана (ВОХР) — вооружённые боевым ручным стрелковым огнестрельным оружием специализированные подразделения охраны с особым правовым статусом...via forma full 5 https://ift.tt/mUOTJ1l Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3580249.html)

Военизированная

Военизированная охрана (ВОХР) — вооружённые боевым ручным стрелковым огнестрельным оружием специализированные подразделения охраны с особым правовым статусом...via forma full 5 https://ift.tt/mUOTJ1l Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Microsoft surges as OpenAI founder Sam Altman joins tech giant to lead AI effort*

Updated at 6:06 AM EST Microsoft (MSFT) - Get Free Report shares powered higher Monday after it said OpenAI founder Sam Altman would lead the tech giant's AI effort following a weekend of boardroom drama that threatened the future of the ChatGPT creator. Microsoft said Altman, as well as his close associate Greg Brockman, will lead a newly-created AI team within the group following the ouster of Altman, and the resignation of Brockman, from OpenAI late Friday. Several key OpenAI employees also threatened to quit the group, which is credited for firing the starting gun on this year's AI investment rush, after a poorly-articulated statement from the board added to the uncertainty tied to Altman's surprise departure. Microsoft CEO Satya Nadella, who lobbied for Altman's return to the helm of OpenAI in the chaotic aftermath of his ousting late Friday, said the tech giant would continue working closely with the ChatGPT creator and its new CEO, former Amazon (AMZN) - Get Free Report Twitch executive Emmett Shear, in the weeks and months ahead. first and last time i ever wear one of these pic.twitter.com/u3iKwyWj0a— Sam Altman (@sama) November 19, 2023 "We remain committed to our partnership with OpenAI and have confidence in our product roadmap, our ability to continue to innovate with everything we announced at Microsoft Ignite, and in continuing to support our customers and partners," Nadella wrote in a post on the X social media website. "We look forward to getting to know Emmett Shear and OAI's new leadership team and working with them. And we’re extremely excited to share the news that Sam Altman and Greg Brockman, together with colleagues, will be joining Microsoft to lead a new advanced AI research team," he added. "We look forward to moving quickly to provide them with the resources needed for their success." Microsoft shares were marked 1.4% higher in pre-market trading to indicate a Monday opening bell price of $375.01 each, a move that would value the Redmond, Washington-based group at around $2.8 trillion. "The train wreck situation at OpenAI created by a four-person board (excluding Altman and Brockman) might go down in tech history as the one of the biggest debacle decisions in the history of Silicon Valley," said Wedbush analyst Dan Ives. Microsoft stock has added more than $1 trillion to its market value so far this year, and alongside Nvidia (NVDA) - Get Free Report, has become one of the hottest tech names in the market, since unveiling a $10 billion investment in OpenAI, the maker of the AI-powered ChatGPT search engine tool, in early January. Microsoft's overall investment of $13 billion, which translates to an equity stake of around 49% in OpenAI, did not come with a board seat. OpenAI's value was last estimated at around $86 billion. The group has touted the potential of ChatGPT, a tool that uses human language to process instructions and which is being embedded in the tech group's also-ran search engine Bing, to close the gap on market leader Google, the eponymous lead product of parent company Alphabet (GOOGL) - Get Free Report. Investors are betting that AI adoption will help Microsoft -- which generated just $3.2 billion in search revenue last year -- challenge the market dominance of Google, which churned around $43 billion.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/microsoft-surges-as-openai-founder-sam-altman-joins-to-lead-ai-effort)

Microsoft surges as OpenAI founder Sam Altman joins tech giant to lead AI effort

Updated at 6:06 AM EST Microsoft (MSFT) - Get Free Report shares powered higher Monday after it said OpenAI founder Sam Altman would lead the tech giant's AI effort following a weekend of boardroom drama that threatened the future of the ChatGPT creator. Microsoft said Altman, as well as his close associate Greg Brockman, will lead a newly-created AI team within the group following the ouster of Altman, and the resignation of Brockman, from OpenAI late Friday. Several key OpenAI employees also threatened to quit the group, which is credited for firing the starting gun on this year's AI investment rush, after a poorly-articulated statement from the board added to the uncertainty tied to Altman's surprise departure. Microsoft CEO Satya Nadella, who lobbied for Altman's return to the helm of OpenAI in the chaotic aftermath of his ousting late Friday, said the tech giant would continue working closely with the ChatGPT creator and its new CEO, former Amazon (AMZN) - Get Free Report Twitch executive Emmett Shear, in the weeks and months ahead. first and last time i ever wear one of these pic.twitter.com/u3iKwyWj0a— Sam Altman (@sama) November 19, 2023 "We remain committed to our partnership with OpenAI and have confidence in our product roadmap, our ability to continue to innovate with everything we announced at Microsoft Ignite, and in continuing to support our customers and partners," Nadella wrote in a post on the X social media website. "We look forward to getting to know Emmett Shear and OAI's new leadership team and working with them. And we’re extremely excited to share the news that Sam Altman and Greg Brockman, together with colleagues, will be joining Microsoft to lead a new advanced AI research team," he added. "We look forward to moving quickly to provide them with the resources needed for their success." Microsoft shares were marked 1.4% higher in pre-market trading to indicate a Monday opening bell price of $375.01 each, a move that would value the Redmond, Washington-based group at around $2.8 trillion. "The train wreck situation at OpenAI created by a four-person board (excluding Altman and Brockman) might go down in tech history as the one of the biggest debacle decisions in the history of Silicon Valley," said Wedbush analyst Dan Ives. Microsoft stock has added more than $1 trillion to its market value so far this year, and alongside Nvidia (NVDA) - Get Free Report, has become one of the hottest tech names in the market, since unveiling a $10 billion investment in OpenAI, the maker of the AI-powered ChatGPT search engine tool, in early January. Microsoft's overall investment of $13 billion, which translates to an equity stake of around 49% in OpenAI, did not come with a board seat. OpenAI's value was last estimated at around $86 billion. The group has touted the potential of ChatGPT, a tool that uses human language to process instructions and which is being embedded in the tech group's also-ran search engine Bing, to close the gap on market leader Google, the eponymous lead product of parent company Alphabet (GOOGL) - Get Free Report. Investors are betting that AI adoption will help Microsoft -- which generated just $3.2 billion in search revenue last year -- challenge the market dominance of Google, which churned around $43 billion.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...

*Подошвы кроссовок*

Фитнес, бег, командные виды спорта, паркур, занятия в зале и на улице требуют определенного типа подошвы спортивной обуви. Например, баскетбольные кроссовки для улицы имеют протектор в виде елочки , иначе игрок будет ...via forma full 5 https://ift.tt/x2XcPMn Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3580841.html)

Подошвы кроссовок

Фитнес, бег, командные виды спорта, паркур, занятия в зале и на улице требуют определенного типа подошвы спортивной обуви. Например, баскетбольные кроссовки для улицы имеют протектор в виде елочки , иначе игрок будет ...via forma full 5 https://ift.tt/x2XcPMn Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Сравнение*

На изображении представлены два пехотинца Красной армии: красноармеец кадровой армии на 22 июня 1941 года и сержант-победитель на 9 мая 1945 года.via forma full 5 https://ift.tt/eVoXyam Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3585532.html)

Сравнение

На изображении представлены два пехотинца Красной армии: красноармеец кадровой армии на 22 июня 1941 года и сержант-победитель на 9 мая 1945 года.via forma full 5 https://ift.tt/eVoXyam Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Форма и камуфляж*

До 2008 года снаряжение спецназа ВС и не относящихся к вооруженным силам ведомств было практически идентичным. Мало того, форма охранника почти полностью копировала обмундирование элитных подразделений, участвующих ...via forma full 5 https://ift.tt/bw2YCIy Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3579766.html)

Форма и камуфляж

До 2008 года снаряжение спецназа ВС и не относящихся к вооруженным силам ведомств было практически идентичным. Мало того, форма охранника почти полностью копировала обмундирование элитных подразделений, участвующих ...via forma full 5 https://ift.tt/bw2YCIy Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
Read more...

*Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug*

Bristol Myers Squibb (BMY) - Get Free Report shares slumped lower in early Monday trading after drugmaker Bayer AG halted late-stage trials of a blood thinning drug that could complicate the development of similar treatments. Bayer shares plunged to a multi-decade low in European trading following a late Sunday update that said its experimental anticoagulant, known as asundexian, was shown to be inferior to Eliquis, a blood-thinner made by Bristol Myers and Pfizer (PFE) - Get Free Report. "This decision is based on the recommendation of the study’s Independent Data Monitoring Committee (IDMC) as part of ongoing surveillance which showed an inferior efficacy of asundexian versus the control arm," Bayer said in a statement. "Although the results from this analysis do not support the continuation of the study, we will continue investigating asundexian and are currently reevaluating other indications in patients in need of antithrombotic treatment," Bayer added. The scrapping of the study, however, has cast doubt on an upcoming 'phase 3' trial of milvexian, a similar 'FIX(a)' inhibitor developed by Bristol Myers and Janssen Pharmaceuticals, a division of Johnson & Johnson (JNJ) - Get Free Report, that will assess its ability to treat patients with various cardio vascular diseases who are at risk to excessive bleeding. The trial, known as Librexia, was granted fast-track approval by the U.S. Food & Drug Administration earlier this year. Bristol Myers had indicated that milvexian could ultimate generate around $5 billion in annual revenues, split with Johnson & Johnson, should it ultimately be approved. Bristol Myers shares were marked 3.6% lower in pre-market trading to indicate an opening bell price of $49.02 each, a move that would still leave the stock with a 25.3% gain over the past six months. Johnson & Johnson shares were marked 0.9% lower at $148.49 each. Bayer shares, meanwhile, were marked 18.8% lower in mid-day Frankfurt trading to change hands at €33.60 each, the lowest levels in more than twelve years.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/bristol-myers-slumps-as-bayer-trial-failure-casts-doubt-on-5-billion-drug)

Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug

Bristol Myers Squibb (BMY) - Get Free Report shares slumped lower in early Monday trading after drugmaker Bayer AG halted late-stage trials of a blood thinning drug that could complicate the development of similar treatments. Bayer shares plunged to a multi-decade low in European trading following a late Sunday update that said its experimental anticoagulant, known as asundexian, was shown to be inferior to Eliquis, a blood-thinner made by Bristol Myers and Pfizer (PFE) - Get Free Report. "This decision is based on the recommendation of the study’s Independent Data Monitoring Committee (IDMC) as part of ongoing surveillance which showed an inferior efficacy of asundexian versus the control arm," Bayer said in a statement. "Although the results from this analysis do not support the continuation of the study, we will continue investigating asundexian and are currently reevaluating other indications in patients in need of antithrombotic treatment," Bayer added. The scrapping of the study, however, has cast doubt on an upcoming 'phase 3' trial of milvexian, a similar 'FIX(a)' inhibitor developed by Bristol Myers and Janssen Pharmaceuticals, a division of Johnson & Johnson (JNJ) - Get Free Report, that will assess its ability to treat patients with various cardio vascular diseases who are at risk to excessive bleeding. The trial, known as Librexia, was granted fast-track approval by the U.S. Food & Drug Administration earlier this year. Bristol Myers had indicated that milvexian could ultimate generate around $5 billion in annual revenues, split with Johnson & Johnson, should it ultimately be approved. Bristol Myers shares were marked 3.6% lower in pre-market trading to indicate an opening bell price of $49.02 each, a move that would still leave the stock with a 25.3% gain over the past six months. Johnson & Johnson shares were marked 0.9% lower at $148.49 each. Bayer shares, meanwhile, were marked 18.8% lower in mid-day Frankfurt trading to change hands at €33.60 each, the lowest levels in more than twelve years.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...

*Казачьи чины*

Казачьи чины — это чины (звания), персонально присваиваемые военнослужащим и военнообязанным (в том числе казакам на льготе)...via forma full 5 https://ift.tt/ElPQv0f Manage Unsubscribe from these notifications or sign in to manage your Email service.IFTTT Manage on IFTTT: https://ifttt.com/myrecipes/personal/114580525
[Read more...](https://analogindex.livejournal.com/3584268.html)